WILSON TROY EDWARD sold 98.7% of their position (27K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $89.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2024ACC: 0001437749-24-020574
Director
Since Jun 2019
-27K
Net shares
Net seller
$89.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−27K
Price / share
$3.33
Trade value
$89.90K
% of position
98.7%
6/13/2024
27.35K→350.00
Total
Net shares
−27K
Net value
-$89.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2024 | S · Sale | −27K | $3.33 | $89.90K | 98.7% | 27.35K | 350.00 |
| Total | −27K | -$89.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned400.00
Common Stock
IndirectShares owned150.00
Total
550.00 indirect550.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 400.00 | Indirect |
| Common Stock | 150.00 | Indirect |
| Total | 550.00 | 550.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported